Trending NewsTrending NewsNASDAQ:DFNS Nukkleus (DFNS) Stock Price, News & Analysis $0.17 -0.01 (-4.21%) As of 06/26/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Nukkleus Stock (NASDAQ:DFNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nukkleus alerts:Sign Up Key Stats Today's Range$0.17▼$0.1850-Day Range$0.17▼$0.7652-Week Range$0.16▼$15.59Volume2.26 million shsAverage Volume24.89 million shsMarket Capitalization$16.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey. Read More Nukkleus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreDFNS MarketRank™: Nukkleus scored higher than 14% of companies evaluated by MarketBeat, and ranked 274th out of 294 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingNukkleus has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNukkleus has only been the subject of 1 research reports in the past 90 days.Read more about Nukkleus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nukkleus are expected to grow in the coming year, from ($0.99) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nukkleus is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nukkleus is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted27.07% of the float of Nukkleus has been sold short.Short Interest Ratio / Days to CoverNukkleus has a short interest ratio ("days to cover") of 0.33, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nukkleus has recently increased by 159.31%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNukkleus does not currently pay a dividend.Dividend GrowthNukkleus does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.79 News SentimentNukkleus has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Nukkleus this week, compared to 3 articles on an average week.Search Interest3 people have searched for DFNS on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows2 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nukkleus insiders have not sold or bought any company stock.Percentage Held by Insiders22.10% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.47% of the stock of Nukkleus is held by institutions.Read more about Nukkleus' insider trading history. Receive DFNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DFNS Stock News HeadlinesT3 Defense to Present at Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference on June 25June 24 at 9:00 AM | globenewswire.comT3 Defense Inc. Announces Private Placement of up to $20 Million to Accelerate Acquisition StrategyJune 16, 2026 | theglobeandmail.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.June 27 at 1:00 AM | Banyan Hill Publishing (Ad)Nimbus Launches Live Red Team Drone Threat Emulation, Deploying Weaponized FPV Systems to Train Forces and Counter-Drone SolutionsJune 16, 2026 | globenewswire.comT3 Defense Announces Attendance at Eurosatory 2026 Defense and Security ConferenceJune 8, 2026 | globenewswire.comT3 Defense to Participate in the Noble Capital Markets Virtual Equity Conference on June 3-4June 1, 2026 | globenewswire.comT3 Defense Subsidiary Nimbus Drones Technologies Establishes UAV LaboratoryMay 28, 2026 | globenewswire.comT3 Defense Subsidiary Tiltan Secures $1.3 Million Order for Advanced Simulation Solution Across Large-Scale Israeli Defense UAS ProgramMay 26, 2026 | globenewswire.comSee More Headlines DFNS Stock Analysis - Frequently Asked Questions How have DFNS shares performed this year? Nukkleus' stock was trading at $4.03 at the beginning of the year. Since then, DFNS shares have decreased by 95.8% and is now trading at $0.1705. How were Nukkleus' earnings last quarter? Nukkleus Inc. (NASDAQ:DFNS) released its quarterly earnings data on Wednesday, May, 20th. The company reported ($1.14) earnings per share (EPS) for the quarter. The firm earned $3.65 million during the quarter. When did Nukkleus' stock split? Shares of Nukkleus reverse split on Thursday, October 24th 2024.The 1-8 reverse split was announced on Friday, October 18th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Nukkleus? Shares of DFNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nukkleus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nukkleus investors own include Lithium Americas (LAC), Meta Platforms (META), Advanced Micro Devices (AMD), Faraday Future Intelligent Electric (FFIE), iSpecimen (ISPC), NVIDIA (NVDA) and Applied Materials (AMAT). Company Calendar Last Earnings5/20/2026Today6/27/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Technology Services Sub-IndustryTrading Current SymbolNASDAQ:DFNS Previous SymbolNASDAQ:NUKK CIK1787518 Webwww.nukk.com Phone212-791-4663FaxN/AEmployees12Year Founded2013Profitability EPS (Trailing Twelve Months)($2.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$78.55 million Net MarginsN/A Pretax Margin-1,443.74% Return on Equity-190.60% Return on Assets-40.70% Debt Debt-to-Equity Ratio0.07 Current Ratio0.25 Quick Ratio0.21 Sales & Book Value Annual Sales$5.91 million Price / Sales2.74 Cash Flow$3.41 per share Price / Cash Flow0.05 Book Value($0.73) per share Price / Book-0.23Miscellaneous Outstanding Shares94,830,000Free Float46,951,000Market Cap$16.17 million OptionableN/A Beta-6.00 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:DFNS) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.